DIAGNOSIS AND MANAGEMENT OF MALIGNANT PLEURAL EFFUSIONS

被引:128
作者
FENTON, KN [1 ]
RICHARDSON, JD [1 ]
机构
[1] UNIV LOUISVILLE,SCH MED,DEPT SURG,LOUISVILLE,KY 40292
关键词
D O I
10.1016/S0002-9610(99)80257-8
中图分类号
R61 [外科手术学];
学科分类号
摘要
Approximately half of all patients with metastatic cancer develop malignant pleural effusions. Because the patients are already terminally ill, these effusions can present Significant diagnos tic and therapeutic challenges, Symptoms are either present at the time of diagnosis or develop subsequently in virtually all cases. The diagnosis is based on chest radiography followed by thoracentesis or thoracoscopy. Most malignant effusions are exudative and about one third are bloody, Cytology is positive for cancer cells in the initial pleural fluid specimens from 60% of patients who are ultimately shown to have malignant effusions. The remaining 40% require a repeat thoracentesis, pleural biopsy, thoracoscopy, or multiple procedures to prove the presence of cancer, Because the average life expectancy of a patient with a malignant pleural effusion is about 6 months, it is important to ob tain a diagnosis expeditiously and formulate a treatment plan that optimizes quality of life, Tube thoracostomy with chemical pleurodesis using doxycycline or bleomycin is the mainstay of current treatment and is about 85% effective,
引用
收藏
页码:69 / 74
页数:6
相关论文
共 27 条
[1]  
Matthay RA, Coppage L, Shaw C, Filderman AE, Malignancies metastatic to the pleura, Invest Radiol, 25, pp. 601-619, (1990)
[2]  
Lynch TE, Management of malignant pleural effusions, Chest, 103, pp. 385S-389S, (1993)
[3]  
Chernow B, Sahn SA, Carcinomatous involvement of the pleura: an analysis of 96 patients, Am J Med, 63, pp. 695-702, (1977)
[4]  
Johnston WW, The malignant pleural effusion: a review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients, Cancer, 56, pp. 905-909, (1985)
[5]  
Sahn SA, Pleural effusions in lung cancer, Clin Chest Med, 14, pp. 189-200, (1993)
[6]  
Rusch VW, Harper GR, Pleural effusions in patients with malignancy, Thoracic Oncology, pp. 594-605, (1989)
[7]  
Monte SA, Ehya H, Lang WR, Positive effusion cytology as the initial presentation of malignancy, Acta Cytol, 31, pp. 448-452, (1987)
[8]  
Van de Molengraft FJJM, Vooijs GP, The interval between the diagnosis of malignancy and the development of effusion, with reference to the role of cytologic diagnosis, Acta Cytol, 32, pp. 183-187, (1988)
[9]  
Hausheer FH, Yarbro JW, Diagnosis and treatment of malignant pleural effusions, Semin Oncol, 12, pp. 54-75, (1985)
[10]  
Meyer PC, Metastatic carcinoma of the pleura, Thorax, 21, pp. 437-443, (1966)